Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome

NCT00362531 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT00362531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00362531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
Lead sponsor
Peking University
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2004
Completion date
January 31, 2007
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic membranous nephropathy, nephrotic syndrome